Multiple Applications of ExpressGraft-C9T1 Skin Tissue as a Treatment for Diabetic Foot Ulcers
Clinical trial NCT04134143 · TERMINATED
Trial details
- NCT number
- NCT04134143
- Sponsor
- Stratatech, a Mallinckrodt Company
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-07
- Primary completion
- 2020-11-25
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.